Delivery Order SPE2DB22D2009-SPE2DB25FL7MQ
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,096.55 firm fixed-price delivery order is for ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a period of performance through November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,675.02 firm fixed-price delivery order is for the supply of ABRYSVO vials with diluent syringes, a medical product. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,919.86 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with an ultimate completion date of November 29, 2024. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,431.99 firm fixed-price delivery order is for 4562267467 ABRYSVO VIAL WITH DILUENTS, with a completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,370.80 Firm Fixed Price Delivery Order contract is for the supply of ABRYSVO VIAL WITH DILUENTS, a medical product, with a completion date of July 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,401.50 Firm Fixed Price Delivery Order contract is for the provision of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,600.96, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product. The contract has a firm fixed-price pricing type and an ultimate completion date of March 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $22,915.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the provision of ABRYSVO VIAL WITH DILUENTS, a medical commodity. This IDC, valued at $999,999,999 and running through November 2026, serves as a primary vehicle for...
This federal contract award, with ID SPE2DB25D3201/SPE2DB25FNQLD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,002.40 firm fixed-price delivery order is for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS" medical products, with a completion date of January 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, is a Delivery Order valued at $4,002.40 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a pharmaceutical product, to support military healthcare programs. The award has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 IDC with the DLA...